The current status of primary prevention in coronary heart disease

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 1, 2001, Pages 24-37

  Pater, Cornel ^a,b  

^a Hertford Medical International   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Cardiac; Population; Prevention; Primary; Risk

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; RESIN;

AGING; ALCOHOL CONSUMPTION; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET; DRUG USE; EXERCISE; FEMALE; FINANCE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROMOTION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFORMATION SYSTEM; ISCHEMIC HEART DISEASE; MALE; MORTALITY; OBESITY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SMOKING CESSATION; TRAINING;

EID: 0035099386     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-1-024     Document Type: Review

References (97)

1. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey
2. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
3. The burden of cardiovascular diseases mortality in Europe. Task force of the ESC on Mortality and Morbidity Statistics in Europe
4. Outcome measurement in economic evaluation
5. Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary artery disease
6. European and American recommendations for coronary heart disease prevention
7. Quality of care for Medicare patients with acute myocardial infarction: A four-state pilot study from the Cooperative Cardiovascular Project
8. A British Cardiac Society survey of the potential for secondary prevention of coronary heart disease
9. A European Society of Cardiology survey of secondary prevention of coronary heart disease
10. Randomized controlled trial of follow-up care in general practice of patients with infarction and angina: Final results of the Southampton Heart Integrated Care Project (SHIP)
11. Development and evaluation of complex interventions in health service research: Case study of the Southampton heart integrated care project (SHIP)
12. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease
13. Organisation of preventive cardiology service
14. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease
15. Can computerised risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS)
16. Periodic health examination 1993 update: Lowering the blood cholesterol level to prevent coronary heart disease
17. Prevention of coronary heart disease in clinical practice
18. Summary of the Second Report of the National Cholesterol Education Program NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel II)
19. Identifying adults at increased risk of coronary heart disease. How well do the current cholesterol guidelines work?
20. How accurately do Canadian physicians assess the coronary risk in their patients? The preliminary results of the Coronary Health Assessment Study (CHAS)
21. Delivery rates of preventive services In 44 Midwestern clinics
22. Our future society: A global challenge
23. Randomized controlled trials in cardiovascular disease: Past achievements, future challenges
24. Cost-effective strategies for reducing coronary risk in primary care
25. Health Information for the developing world
26. World Bank. Investing in health: The 1993 World Development Report of the World Bank
27. Telemedicine in the national health service
28. The potential for telemedicine in home nursing
29. Evidence based medicine: A new approach to teaching the practice of medicine
30. Evaluation and management of risk factors for the individual patient (case management)
31. A British Cardiac Society survey of the potential for secondary prevention of coronary disease: ASPIRE
32. Prediction of coronary heart disease using risk factor categories
33. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events
34. Cardiovascular disease
35. Conclusions and recommendations
36. British Hyperlipidaemia Association guidelines on strategies for reduction of coronary heart disease and desirable levels for blood lipid levels
37. Management of hyperlipidaemia: Guidelines of the British Hyperlipidaemia Association
38. Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society
39. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
40. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking
41. Effect of diet and smoking intervention on the incidence of coronary heart disease
42. The risk of myocardial infarction after quitting smoking in men under 55 years of age
43. Decline in the risk of myocardial infarction among women who stop smoking
44. ACC/AHA/ACPASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force of Practice Guidelines
45. Long-term effect on mortality of stopping smoking after unstable angina and myocardial infarction
46. Changes in diet in Finland from 1972 to 1992: Impact on coronary heart disease risk
47. Plant sterol and sterol margarines and health
48. Effects of changes in fat, fish, and fibres intakes on death and myocardial reinfarction: Diet and reinfarction trial
49. Comparison of the prediction, by 27 different factors, of coronary heart disease and death in men and women of a Scottish heart health study: Cohort study
50. The association of changes in physical activity level and other lifestyle characteristics with mortality among men
51. Changes in physical activity, mortality, and incidence of coronary heart disease in older men
52. Mortality in relation to consumption of alcohol: 13 years of observation in male British doctors
53. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits
54. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. UKPDS
55. Prevention of coronary heart disease in clinical practice: Recommendation of the Second Joint Task Force of European and other SocIeties on Coronary Prevention
56. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
57. Body weight implications for the prevention of coronary heart disease, stroke and diabetes mellitus in a cohort study of middle-aged men
58. Weight, weight change, and coronary heart disease In women. Risk within the "normal" weight range
59. Prevention of coronary heart disease in clinical practice
60. Cardiovascular disease risk profiles
61. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
62. Assessment of cardiovascular risk by use of a multiple-risk-factor assessment equations
63. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
64. Prediction of coronary heart disease using risk factor categories
65. Joint British recommendations prevention of coronary heart disease in clinical practice
66. What is the optimal age for starting lipid lowering treatment? A mathematical model
67. CHD risk equations, obtained from the Framingham study, applied to PROCAM study
68. Is the Framingham risk function valid for Northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
69. nd report of the WHO-ERICA Project
70. Comparisons of the Framingham risk function-based coronary risk chart with risk function from an Italian population study
71. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia
72. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population
73. Joint British recommendations on prevention of coronary heart disease in clinical practice
74. Prevention of coronary heart disease in clinical practice: Recommendations of the second joint task force of European and other societies on coronary prevention
75. British Hypertension Society guidelines for hypertension management 1999: Summary
76. Management of raised blood pressure in New Zealand: A discussion document
77. A simple computer program for cardiovascular risk factor management and prescribing guidance
78. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
79. Secondary prevention in coronary heart disease: Baseline survey of provision in general practice
80. Sheffield tables have shortcomings
81. The 'Singapore declaration: Forging the will for heart health in the next millennium
82. Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361662 men
83. Community-based prevention trials: Challenges and directions for public health practice, policy, and research
84. Epidemiological basis of a community strategy for prevention of cardiopulmonary disease
85. Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the task force on risk reduction
86. Organisation of preventive cardiology service
87. Serum cholesterol, blood pressure, and mortality